EXPLAINER: ANKTIVA- The Next Great Longevity Drug?

About this episode

Robert Lufkin MD discusses the implications of lymphopenia and the potential of ANKTIVA as a longevity drug.

There's a single number on your routine blood test that predicts your risk of dying from cancer, heart disease, and infection better than cholesterol — and an FDA-approved drug may now move it. In this Health Longevity Secrets explainer, Robert Lufkin MD breaks down lymphopenia, the IL-15 cytokine, and ANKTIVA (nogapendekin alfa inbakicept) — the first FDA-approved IL-15 super-agonist and possibly one of the most important longevity drugs of the decade. CHAPTERS: 00:00 — Introduction: The Bl...

People in this episode

Host: Robert Lufkin MD

Topics covered

• longevity
• health
• blood test
• cancer
• heart disease
• IL-15
• ANKTIVA

Keywords

• longevity drug
• ANKTIVA
• lymphopenia
• IL-15 cytokine
• FDA-approved
• health risks
• blood test

Mentioned in this episode

Organizations: FDA, IL-15, IL-15 super-agonist

Products: ANKTIVA, nogapendekin alfa inbakicept

More episodes of Health Longevity Secrets

• EXPLAINER: Does Creatine Cause Cancer? What the Science Actually Says · June 11, 2026 · 10 min
• The Smart Toilet That Could Detect Cancer Before You Know You Have It | Scott Hickle (Throne) · June 9, 2026 · 42 min
• EXPLAINER: Sleep Isn't For Muscle Repair — Here's What It's Actually For · June 4, 2026 · 12 min
• Are We In A Longevity Revolution? — David Donnelly (Director, Forever Young) · June 2, 2026 · 44 min
• The Army Ranger Who Found Magic Mushrooms Save Lives — Neil Markey (Beckley Retreats) · May 26, 2026 · 48 min
• EXPLAINER: 5 Longevity Myths the Latest Science Has Debunked · May 21, 2026 · 9 min